- Home
- RVMD vs CELH Comparison
RVMD vs CELH Comparison
Compare RVMD & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | CELH |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 12.5B |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | RVMD | CELH |
|---|---|---|
| Price | $96.61 | $40.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 17 |
| Target Price | ★ $117.33 | $66.50 |
| AVG Volume (30 Days) | 1.6M | ★ 5.5M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $1,318,014,000.00 |
| Revenue This Year | N/A | $37.68 |
| Revenue Next Year | $454.85 | $10.02 |
| P/E Ratio | ★ N/A | $166.52 |
| Revenue Growth | N/A | ★ 101.65 |
| 52 Week Low | $29.17 | $32.36 |
| 52 Week High | $124.49 | $66.74 |
Technical Indicators
Market Signals| Indicator | RVMD | CELH |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 36.12 |
| Support Level | $93.86 | $37.45 |
| Resistance Level | $107.45 | $47.00 |
| Average True Range (ATR) | 3.03 | 2.07 |
| MACD | -0.30 | -0.38 |
| Stochastic Oscillator | 25.55 | 3.46 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.